Core Viewpoint - Pharma-Bio Serv, Inc. reported a revenue of approximately $9.0 million for the year ended October 31, 2025, reflecting a decrease of about $0.5 million compared to the previous year, while also showing a net loss improvement of approximately $0.7 million year-over-year [1][1][1] Financial Performance - Revenues for the year ended October 31, 2025, were approximately $9.0 million, down from the previous year [1] - The net loss for the same period was approximately $0.1 million, which is an improvement of approximately $0.7 million compared to the last year [1]

Core Insights - Pharma-Bio Serv, Inc. reported revenues of approximately $2.0 million for the three months ended July 31, 2025, a decrease from $2.4 million in the same period of 2024 [1] - For the nine months ended July 31, 2025, revenues were approximately $6.9 million, down from $7.2 million for the same period in 2024 [1] Revenue Analysis - The revenue for the three months ended July 31, 2025, decreased by approximately 16.67% compared to the same period in 2024 [1] - The revenue for the nine months ended July 31, 2025, decreased by approximately 4.17% compared to the same period in 2024 [1]